Global Respiratory Syncytial Virus Vaccine for Children Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Respiratory Syncytial Virus Vaccine for Children market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Respiratory Syncytial Virus Vaccine for Children Industry Forecast” looks at past sales and reviews total world Respiratory Syncytial Virus Vaccine for Children sales in 2023, providing a comprehensive analysis by region and market sector of projected Respiratory Syncytial Virus Vaccine for Children sales for 2024 through 2030. With Respiratory Syncytial Virus Vaccine for Children sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Respiratory Syncytial Virus Vaccine for Children industry.
This Insight Report provides a comprehensive analysis of the global Respiratory Syncytial Virus Vaccine for Children landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Respiratory Syncytial Virus Vaccine for Children portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Respiratory Syncytial Virus Vaccine for Children market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Respiratory Syncytial Virus Vaccine for Children and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Respiratory Syncytial Virus Vaccine for Children.
United States market for Respiratory Syncytial Virus Vaccine for Children is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Respiratory Syncytial Virus Vaccine for Children is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Respiratory Syncytial Virus Vaccine for Children is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Respiratory Syncytial Virus Vaccine for Children players cover Moderna, Sanofi, Meissa, Blue Lake Biotechnology, Codagenix, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Respiratory Syncytial Virus Vaccine for Children market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Respiratory Syncytial Virus Vaccine for Children market?
What factors are driving Respiratory Syncytial Virus Vaccine for Children market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Respiratory Syncytial Virus Vaccine for Children market opportunities vary by end market size?
How does Respiratory Syncytial Virus Vaccine for Children break out by Type, by Application?
The global Respiratory Syncytial Virus Vaccine for Children market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Respiratory Syncytial Virus Vaccine for Children Industry Forecast” looks at past sales and reviews total world Respiratory Syncytial Virus Vaccine for Children sales in 2023, providing a comprehensive analysis by region and market sector of projected Respiratory Syncytial Virus Vaccine for Children sales for 2024 through 2030. With Respiratory Syncytial Virus Vaccine for Children sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Respiratory Syncytial Virus Vaccine for Children industry.
This Insight Report provides a comprehensive analysis of the global Respiratory Syncytial Virus Vaccine for Children landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Respiratory Syncytial Virus Vaccine for Children portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Respiratory Syncytial Virus Vaccine for Children market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Respiratory Syncytial Virus Vaccine for Children and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Respiratory Syncytial Virus Vaccine for Children.
United States market for Respiratory Syncytial Virus Vaccine for Children is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Respiratory Syncytial Virus Vaccine for Children is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Respiratory Syncytial Virus Vaccine for Children is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Respiratory Syncytial Virus Vaccine for Children players cover Moderna, Sanofi, Meissa, Blue Lake Biotechnology, Codagenix, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Respiratory Syncytial Virus Vaccine for Children market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Recombinant Protein Vaccine
- Nucleic Acid Vaccine
- Others
- Hospital
- Centers for Disease Control and Prevention
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Moderna
- Sanofi
- Meissa
- Blue Lake Biotechnology
- Codagenix
- Novavax
- Pfizer
- Wits Health Consortium (Pty) Ltd
- Advaccine
- Clover Biopharma
What is the 10-year outlook for the global Respiratory Syncytial Virus Vaccine for Children market?
What factors are driving Respiratory Syncytial Virus Vaccine for Children market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Respiratory Syncytial Virus Vaccine for Children market opportunities vary by end market size?
How does Respiratory Syncytial Virus Vaccine for Children break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Respiratory Syncytial Virus Vaccine for Children Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Respiratory Syncytial Virus Vaccine for Children by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Respiratory Syncytial Virus Vaccine for Children by Country/Region, 2019, 2023 & 2030
2.2 Respiratory Syncytial Virus Vaccine for Children Segment by Type
2.2.1 Recombinant Protein Vaccine
2.2.2 Nucleic Acid Vaccine
2.2.3 Others
2.3 Respiratory Syncytial Virus Vaccine for Children Sales by Type
2.3.1 Global Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Type (2019-2024)
2.3.2 Global Respiratory Syncytial Virus Vaccine for Children Revenue and Market Share by Type (2019-2024)
2.3.3 Global Respiratory Syncytial Virus Vaccine for Children Sale Price by Type (2019-2024)
2.4 Respiratory Syncytial Virus Vaccine for Children Segment by Application
2.4.1 Hospital
2.4.2 Centers for Disease Control and Prevention
2.4.3 Others
2.5 Respiratory Syncytial Virus Vaccine for Children Sales by Application
2.5.1 Global Respiratory Syncytial Virus Vaccine for Children Sale Market Share by Application (2019-2024)
2.5.2 Global Respiratory Syncytial Virus Vaccine for Children Revenue and Market Share by Application (2019-2024)
2.5.3 Global Respiratory Syncytial Virus Vaccine for Children Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Respiratory Syncytial Virus Vaccine for Children Breakdown Data by Company
3.1.1 Global Respiratory Syncytial Virus Vaccine for Children Annual Sales by Company (2019-2024)
3.1.2 Global Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Company (2019-2024)
3.2 Global Respiratory Syncytial Virus Vaccine for Children Annual Revenue by Company (2019-2024)
3.2.1 Global Respiratory Syncytial Virus Vaccine for Children Revenue by Company (2019-2024)
3.2.2 Global Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Company (2019-2024)
3.3 Global Respiratory Syncytial Virus Vaccine for Children Sale Price by Company
3.4 Key Manufacturers Respiratory Syncytial Virus Vaccine for Children Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Respiratory Syncytial Virus Vaccine for Children Product Location Distribution
3.4.2 Players Respiratory Syncytial Virus Vaccine for Children Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN BY GEOGRAPHIC REGION
4.1 World Historic Respiratory Syncytial Virus Vaccine for Children Market Size by Geographic Region (2019-2024)
4.1.1 Global Respiratory Syncytial Virus Vaccine for Children Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Respiratory Syncytial Virus Vaccine for Children Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Respiratory Syncytial Virus Vaccine for Children Market Size by Country/Region (2019-2024)
4.2.1 Global Respiratory Syncytial Virus Vaccine for Children Annual Sales by Country/Region (2019-2024)
4.2.2 Global Respiratory Syncytial Virus Vaccine for Children Annual Revenue by Country/Region (2019-2024)
4.3 Americas Respiratory Syncytial Virus Vaccine for Children Sales Growth
4.4 APAC Respiratory Syncytial Virus Vaccine for Children Sales Growth
4.5 Europe Respiratory Syncytial Virus Vaccine for Children Sales Growth
4.6 Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Sales Growth
5 AMERICAS
5.1 Americas Respiratory Syncytial Virus Vaccine for Children Sales by Country
5.1.1 Americas Respiratory Syncytial Virus Vaccine for Children Sales by Country (2019-2024)
5.1.2 Americas Respiratory Syncytial Virus Vaccine for Children Revenue by Country (2019-2024)
5.2 Americas Respiratory Syncytial Virus Vaccine for Children Sales by Type (2019-2024)
5.3 Americas Respiratory Syncytial Virus Vaccine for Children Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Respiratory Syncytial Virus Vaccine for Children Sales by Region
6.1.1 APAC Respiratory Syncytial Virus Vaccine for Children Sales by Region (2019-2024)
6.1.2 APAC Respiratory Syncytial Virus Vaccine for Children Revenue by Region (2019-2024)
6.2 APAC Respiratory Syncytial Virus Vaccine for Children Sales by Type (2019-2024)
6.3 APAC Respiratory Syncytial Virus Vaccine for Children Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Respiratory Syncytial Virus Vaccine for Children by Country
7.1.1 Europe Respiratory Syncytial Virus Vaccine for Children Sales by Country (2019-2024)
7.1.2 Europe Respiratory Syncytial Virus Vaccine for Children Revenue by Country (2019-2024)
7.2 Europe Respiratory Syncytial Virus Vaccine for Children Sales by Type (2019-2024)
7.3 Europe Respiratory Syncytial Virus Vaccine for Children Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Respiratory Syncytial Virus Vaccine for Children by Country
8.1.1 Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Sales by Country (2019-2024)
8.1.2 Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Revenue by Country (2019-2024)
8.2 Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Sales by Type (2019-2024)
8.3 Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Respiratory Syncytial Virus Vaccine for Children
10.3 Manufacturing Process Analysis of Respiratory Syncytial Virus Vaccine for Children
10.4 Industry Chain Structure of Respiratory Syncytial Virus Vaccine for Children
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Respiratory Syncytial Virus Vaccine for Children Distributors
11.3 Respiratory Syncytial Virus Vaccine for Children Customer
12 WORLD FORECAST REVIEW FOR RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN BY GEOGRAPHIC REGION
12.1 Global Respiratory Syncytial Virus Vaccine for Children Market Size Forecast by Region
12.1.1 Global Respiratory Syncytial Virus Vaccine for Children Forecast by Region (2025-2030)
12.1.2 Global Respiratory Syncytial Virus Vaccine for Children Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Respiratory Syncytial Virus Vaccine for Children Forecast by Type (2025-2030)
12.7 Global Respiratory Syncytial Virus Vaccine for Children Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Moderna
13.1.1 Moderna Company Information
13.1.2 Moderna Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
13.1.3 Moderna Respiratory Syncytial Virus Vaccine for Children Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Moderna Main Business Overview
13.1.5 Moderna Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
13.2.3 Sanofi Respiratory Syncytial Virus Vaccine for Children Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Meissa
13.3.1 Meissa Company Information
13.3.2 Meissa Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
13.3.3 Meissa Respiratory Syncytial Virus Vaccine for Children Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Meissa Main Business Overview
13.3.5 Meissa Latest Developments
13.4 Blue Lake Biotechnology
13.4.1 Blue Lake Biotechnology Company Information
13.4.2 Blue Lake Biotechnology Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
13.4.3 Blue Lake Biotechnology Respiratory Syncytial Virus Vaccine for Children Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Blue Lake Biotechnology Main Business Overview
13.4.5 Blue Lake Biotechnology Latest Developments
13.5 Codagenix
13.5.1 Codagenix Company Information
13.5.2 Codagenix Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
13.5.3 Codagenix Respiratory Syncytial Virus Vaccine for Children Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Codagenix Main Business Overview
13.5.5 Codagenix Latest Developments
13.6 Novavax
13.6.1 Novavax Company Information
13.6.2 Novavax Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
13.6.3 Novavax Respiratory Syncytial Virus Vaccine for Children Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Novavax Main Business Overview
13.6.5 Novavax Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
13.7.3 Pfizer Respiratory Syncytial Virus Vaccine for Children Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Wits Health Consortium (Pty) Ltd
13.8.1 Wits Health Consortium (Pty) Ltd Company Information
13.8.2 Wits Health Consortium (Pty) Ltd Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
13.8.3 Wits Health Consortium (Pty) Ltd Respiratory Syncytial Virus Vaccine for Children Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Wits Health Consortium (Pty) Ltd Main Business Overview
13.8.5 Wits Health Consortium (Pty) Ltd Latest Developments
13.9 Advaccine
13.9.1 Advaccine Company Information
13.9.2 Advaccine Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
13.9.3 Advaccine Respiratory Syncytial Virus Vaccine for Children Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Advaccine Main Business Overview
13.9.5 Advaccine Latest Developments
13.10 Clover Biopharma
13.10.1 Clover Biopharma Company Information
13.10.2 Clover Biopharma Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
13.10.3 Clover Biopharma Respiratory Syncytial Virus Vaccine for Children Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Clover Biopharma Main Business Overview
13.10.5 Clover Biopharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Respiratory Syncytial Virus Vaccine for Children Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Respiratory Syncytial Virus Vaccine for Children Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Recombinant Protein Vaccine
Table 4. Major Players of Nucleic Acid Vaccine
Table 5. Major Players of Others
Table 6. Global Respiratory Syncytial Virus Vaccine for Children Sales byType (2019-2024) & (Dose)
Table 7. Global Respiratory Syncytial Virus Vaccine for Children Sales Market Share byType (2019-2024)
Table 8. Global Respiratory Syncytial Virus Vaccine for Children Revenue byType (2019-2024) & ($ million)
Table 9. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market Share byType (2019-2024)
Table 10. Global Respiratory Syncytial Virus Vaccine for Children Sale Price byType (2019-2024) & (US$/Dose)
Table 11. Global Respiratory Syncytial Virus Vaccine for Children Sale by Application (2019-2024) & (Dose)
Table 12. Global Respiratory Syncytial Virus Vaccine for Children Sale Market Share by Application (2019-2024)
Table 13. Global Respiratory Syncytial Virus Vaccine for Children Revenue by Application (2019-2024) & ($ million)
Table 14. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Application (2019-2024)
Table 15. Global Respiratory Syncytial Virus Vaccine for Children Sale Price by Application (2019-2024) & (US$/Dose)
Table 16. Global Respiratory Syncytial Virus Vaccine for Children Sales by Company (2019-2024) & (Dose)
Table 17. Global Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Company (2019-2024)
Table 18. Global Respiratory Syncytial Virus Vaccine for Children Revenue by Company (2019-2024) & ($ millions)
Table 19. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Company (2019-2024)
Table 20. Global Respiratory Syncytial Virus Vaccine for Children Sale Price by Company (2019-2024) & (US$/Dose)
Table 21. Key Manufacturers Respiratory Syncytial Virus Vaccine for Children Producing Area Distribution and Sales Area
Table 22. Players Respiratory Syncytial Virus Vaccine for Children Products Offered
Table 23. Respiratory Syncytial Virus Vaccine for Children Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Respiratory Syncytial Virus Vaccine for Children Sales by Geographic Region (2019-2024) & (Dose)
Table 27. Global Respiratory Syncytial Virus Vaccine for Children Sales Market Share Geographic Region (2019-2024)
Table 28. Global Respiratory Syncytial Virus Vaccine for Children Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Respiratory Syncytial Virus Vaccine for Children Sales by Country/Region (2019-2024) & (Dose)
Table 31. Global Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Country/Region (2019-2024)
Table 32. Global Respiratory Syncytial Virus Vaccine for Children Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Respiratory Syncytial Virus Vaccine for Children Sales by Country (2019-2024) & (Dose)
Table 35. Americas Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Country (2019-2024)
Table 36. Americas Respiratory Syncytial Virus Vaccine for Children Revenue by Country (2019-2024) & ($ millions)
Table 37. Americas Respiratory Syncytial Virus Vaccine for Children Sales byType (2019-2024) & (Dose)
Table 38. Americas Respiratory Syncytial Virus Vaccine for Children Sales by Application (2019-2024) & (Dose)
Table 39. APAC Respiratory Syncytial Virus Vaccine for Children Sales by Region (2019-2024) & (Dose)
Table 40. APAC Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Region (2019-2024)
Table 41. APAC Respiratory Syncytial Virus Vaccine for Children Revenue by Region (2019-2024) & ($ millions)
Table 42. APAC Respiratory Syncytial Virus Vaccine for Children Sales byType (2019-2024) & (Dose)
Table 43. APAC Respiratory Syncytial Virus Vaccine for Children Sales by Application (2019-2024) & (Dose)
Table 44. Europe Respiratory Syncytial Virus Vaccine for Children Sales by Country (2019-2024) & (Dose)
Table 45. Europe Respiratory Syncytial Virus Vaccine for Children Revenue by Country (2019-2024) & ($ millions)
Table 46. Europe Respiratory Syncytial Virus Vaccine for Children Sales byType (2019-2024) & (Dose)
Table 47. Europe Respiratory Syncytial Virus Vaccine for Children Sales by Application (2019-2024) & (Dose)
Table 48. Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Sales by Country (2019-2024) & (Dose)
Table 49. Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Country (2019-2024)
Table 50. Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Sales byType (2019-2024) & (Dose)
Table 51. Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Sales by Application (2019-2024) & (Dose)
Table 52. Key Market Drivers & Growth Opportunities of Respiratory Syncytial Virus Vaccine for Children
Table 53. Key Market Challenges & Risks of Respiratory Syncytial Virus Vaccine for Children
Table 54. Key IndustryTrends of Respiratory Syncytial Virus Vaccine for Children
Table 55. Respiratory Syncytial Virus Vaccine for Children Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Respiratory Syncytial Virus Vaccine for Children Distributors List
Table 58. Respiratory Syncytial Virus Vaccine for Children Customer List
Table 59. Global Respiratory Syncytial Virus Vaccine for Children SalesForecast by Region (2025-2030) & (Dose)
Table 60. Global Respiratory Syncytial Virus Vaccine for Children RevenueForecast by Region (2025-2030) & ($ millions)
Table 61. Americas Respiratory Syncytial Virus Vaccine for Children SalesForecast by Country (2025-2030) & (Dose)
Table 62. Americas Respiratory Syncytial Virus Vaccine for Children Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 63. APAC Respiratory Syncytial Virus Vaccine for Children SalesForecast by Region (2025-2030) & (Dose)
Table 64. APAC Respiratory Syncytial Virus Vaccine for Children Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 65. Europe Respiratory Syncytial Virus Vaccine for Children SalesForecast by Country (2025-2030) & (Dose)
Table 66. Europe Respiratory Syncytial Virus Vaccine for Children RevenueForecast by Country (2025-2030) & ($ millions)
Table 67. Middle East & Africa Respiratory Syncytial Virus Vaccine for Children SalesForecast by Country (2025-2030) & (Dose)
Table 68. Middle East & Africa Respiratory Syncytial Virus Vaccine for Children RevenueForecast by Country (2025-2030) & ($ millions)
Table 69. Global Respiratory Syncytial Virus Vaccine for Children SalesForecast byType (2025-2030) & (Dose)
Table 70. Global Respiratory Syncytial Virus Vaccine for Children RevenueForecast byType (2025-2030) & ($ millions)
Table 71. Global Respiratory Syncytial Virus Vaccine for Children SalesForecast by Application (2025-2030) & (Dose)
Table 72. Global Respiratory Syncytial Virus Vaccine for Children RevenueForecast by Application (2025-2030) & ($ millions)
Table 73. Moderna Basic Information, Respiratory Syncytial Virus Vaccine for Children Manufacturing Base, Sales Area and Its Competitors
Table 74. Moderna Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
Table 75. Moderna Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 76. Moderna Main Business
Table 77. Moderna Latest Developments
Table 78. Sanofi Basic Information, Respiratory Syncytial Virus Vaccine for Children Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
Table 80. Sanofi Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 81. Sanofi Main Business
Table 82. Sanofi Latest Developments
Table 83. Meissa Basic Information, Respiratory Syncytial Virus Vaccine for Children Manufacturing Base, Sales Area and Its Competitors
Table 84. Meissa Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
Table 85. Meissa Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 86. Meissa Main Business
Table 87. Meissa Latest Developments
Table 88. Blue Lake Biotechnology Basic Information, Respiratory Syncytial Virus Vaccine for Children Manufacturing Base, Sales Area and Its Competitors
Table 89. Blue Lake Biotechnology Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
Table 90. Blue Lake Biotechnology Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 91. Blue Lake Biotechnology Main Business
Table 92. Blue Lake Biotechnology Latest Developments
Table 93. Codagenix Basic Information, Respiratory Syncytial Virus Vaccine for Children Manufacturing Base, Sales Area and Its Competitors
Table 94. Codagenix Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
Table 95. Codagenix Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 96. Codagenix Main Business
Table 97. Codagenix Latest Developments
Table 98. Novavax Basic Information, Respiratory Syncytial Virus Vaccine for Children Manufacturing Base, Sales Area and Its Competitors
Table 99. Novavax Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
Table 100. Novavax Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 101. Novavax Main Business
Table 102. Novavax Latest Developments
Table 103. Pfizer Basic Information, Respiratory Syncytial Virus Vaccine for Children Manufacturing Base, Sales Area and Its Competitors
Table 104. Pfizer Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
Table 105. Pfizer Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 106. Pfizer Main Business
Table 107. Pfizer Latest Developments
Table 108. Wits Health Consortium (Pty) Ltd Basic Information, Respiratory Syncytial Virus Vaccine for Children Manufacturing Base, Sales Area and Its Competitors
Table 109. Wits Health Consortium (Pty) Ltd Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
Table 110. Wits Health Consortium (Pty) Ltd Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 111. Wits Health Consortium (Pty) Ltd Main Business
Table 112. Wits Health Consortium (Pty) Ltd Latest Developments
Table 113. Advaccine Basic Information, Respiratory Syncytial Virus Vaccine for Children Manufacturing Base, Sales Area and Its Competitors
Table 114. Advaccine Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
Table 115. Advaccine Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 116. Advaccine Main Business
Table 117. Advaccine Latest Developments
Table 118. Clover Biopharma Basic Information, Respiratory Syncytial Virus Vaccine for Children Manufacturing Base, Sales Area and Its Competitors
Table 119. Clover Biopharma Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
Table 120. Clover Biopharma Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 121. Clover Biopharma Main Business
Table 122. Clover Biopharma Latest Developments
LIST OFFIGURES
Figure 1. Picture of Respiratory Syncytial Virus Vaccine for Children
Figure 2. Respiratory Syncytial Virus Vaccine for Children Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Respiratory Syncytial Virus Vaccine for Children Sales Growth Rate 2019-2030 (Dose)
Figure 7. Global Respiratory Syncytial Virus Vaccine for Children Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Respiratory Syncytial Virus Vaccine for Children Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Country/Region (2023)
Figure 10. Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Recombinant Protein Vaccine
Figure 12. Product Picture of Nucleic Acid Vaccine
Figure 13. Product Picture of Others
Figure 14. Global Respiratory Syncytial Virus Vaccine for Children Sales Market Share byType in 2023
Figure 15. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market Share byType (2019-2024)
Figure 16. Respiratory Syncytial Virus Vaccine for Children Consumed in Hospital
Figure 17. Global Respiratory Syncytial Virus Vaccine for Children Market: Hospital (2019-2024) & (Dose)
Figure 18. Respiratory Syncytial Virus Vaccine for Children Consumed in Centers for Disease Control and Prevention
Figure 19. Global Respiratory Syncytial Virus Vaccine for Children Market: Centers for Disease Control and Prevention (2019-2024) & (Dose)
Figure 20. Respiratory Syncytial Virus Vaccine for Children Consumed in Others
Figure 21. Global Respiratory Syncytial Virus Vaccine for Children Market: Others (2019-2024) & (Dose)
Figure 22. Global Respiratory Syncytial Virus Vaccine for Children Sale Market Share by Application (2023)
Figure 23. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Application in 2023
Figure 24. Respiratory Syncytial Virus Vaccine for Children Sales by Company in 2023 (Dose)
Figure 25. Global Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Company in 2023
Figure 26. Respiratory Syncytial Virus Vaccine for Children Revenue by Company in 2023 ($ millions)
Figure 27. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Company in 2023
Figure 28. Global Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Geographic Region in 2023
Figure 30. Americas Respiratory Syncytial Virus Vaccine for Children Sales 2019-2024 (Dose)
Figure 31. Americas Respiratory Syncytial Virus Vaccine for Children Revenue 2019-2024 ($ millions)
Figure 32. APAC Respiratory Syncytial Virus Vaccine for Children Sales 2019-2024 (Dose)
Figure 33. APAC Respiratory Syncytial Virus Vaccine for Children Revenue 2019-2024 ($ millions)
Figure 34. Europe Respiratory Syncytial Virus Vaccine for Children Sales 2019-2024 (Dose)
Figure 35. Europe Respiratory Syncytial Virus Vaccine for Children Revenue 2019-2024 ($ millions)
Figure 36. Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Sales 2019-2024 (Dose)
Figure 37. Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Revenue 2019-2024 ($ millions)
Figure 38. Americas Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Country in 2023
Figure 39. Americas Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Country (2019-2024)
Figure 40. Americas Respiratory Syncytial Virus Vaccine for Children Sales Market Share byType (2019-2024)
Figure 41. Americas Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Application (2019-2024)
Figure 42. United States Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 43. Canada Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 44. Mexico Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 45. Brazil Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 46. APAC Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Region in 2023
Figure 47. APAC Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Region (2019-2024)
Figure 48. APAC Respiratory Syncytial Virus Vaccine for Children Sales Market Share byType (2019-2024)
Figure 49. APAC Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Application (2019-2024)
Figure 50. China Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 51. Japan Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 52. South Korea Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 53. Southeast Asia Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 54. India Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 55. Australia Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 56. ChinaTaiwan Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 57. Europe Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Country in 2023
Figure 58. Europe Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Country (2019-2024)
Figure 59. Europe Respiratory Syncytial Virus Vaccine for Children Sales Market Share byType (2019-2024)
Figure 60. Europe Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Application (2019-2024)
Figure 61. Germany Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 62.France Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 63. UK Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 64. Italy Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 65. Russia Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 66. Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Country (2019-2024)
Figure 67. Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Sales Market Share byType (2019-2024)
Figure 68. Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Application (2019-2024)
Figure 69. Egypt Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 70. South Africa Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 71. Israel Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 72.Turkey Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 73. GCC Countries Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Respiratory Syncytial Virus Vaccine for Children in 2023
Figure 75. Manufacturing Process Analysis of Respiratory Syncytial Virus Vaccine for Children
Figure 76. Industry Chain Structure of Respiratory Syncytial Virus Vaccine for Children
Figure 77. Channels of Distribution
Figure 78. Global Respiratory Syncytial Virus Vaccine for Children Sales MarketForecast by Region (2025-2030)
Figure 79. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market ShareForecast by Region (2025-2030)
Figure 80. Global Respiratory Syncytial Virus Vaccine for Children Sales Market ShareForecast byType (2025-2030)
Figure 81. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market ShareForecast byType (2025-2030)
Figure 82. Global Respiratory Syncytial Virus Vaccine for Children Sales Market ShareForecast by Application (2025-2030)
Figure 83. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market ShareForecast by Application (2025-2030)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Respiratory Syncytial Virus Vaccine for Children Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Respiratory Syncytial Virus Vaccine for Children by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Respiratory Syncytial Virus Vaccine for Children by Country/Region, 2019, 2023 & 2030
2.2 Respiratory Syncytial Virus Vaccine for Children Segment by Type
2.2.1 Recombinant Protein Vaccine
2.2.2 Nucleic Acid Vaccine
2.2.3 Others
2.3 Respiratory Syncytial Virus Vaccine for Children Sales by Type
2.3.1 Global Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Type (2019-2024)
2.3.2 Global Respiratory Syncytial Virus Vaccine for Children Revenue and Market Share by Type (2019-2024)
2.3.3 Global Respiratory Syncytial Virus Vaccine for Children Sale Price by Type (2019-2024)
2.4 Respiratory Syncytial Virus Vaccine for Children Segment by Application
2.4.1 Hospital
2.4.2 Centers for Disease Control and Prevention
2.4.3 Others
2.5 Respiratory Syncytial Virus Vaccine for Children Sales by Application
2.5.1 Global Respiratory Syncytial Virus Vaccine for Children Sale Market Share by Application (2019-2024)
2.5.2 Global Respiratory Syncytial Virus Vaccine for Children Revenue and Market Share by Application (2019-2024)
2.5.3 Global Respiratory Syncytial Virus Vaccine for Children Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Respiratory Syncytial Virus Vaccine for Children Breakdown Data by Company
3.1.1 Global Respiratory Syncytial Virus Vaccine for Children Annual Sales by Company (2019-2024)
3.1.2 Global Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Company (2019-2024)
3.2 Global Respiratory Syncytial Virus Vaccine for Children Annual Revenue by Company (2019-2024)
3.2.1 Global Respiratory Syncytial Virus Vaccine for Children Revenue by Company (2019-2024)
3.2.2 Global Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Company (2019-2024)
3.3 Global Respiratory Syncytial Virus Vaccine for Children Sale Price by Company
3.4 Key Manufacturers Respiratory Syncytial Virus Vaccine for Children Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Respiratory Syncytial Virus Vaccine for Children Product Location Distribution
3.4.2 Players Respiratory Syncytial Virus Vaccine for Children Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN BY GEOGRAPHIC REGION
4.1 World Historic Respiratory Syncytial Virus Vaccine for Children Market Size by Geographic Region (2019-2024)
4.1.1 Global Respiratory Syncytial Virus Vaccine for Children Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Respiratory Syncytial Virus Vaccine for Children Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Respiratory Syncytial Virus Vaccine for Children Market Size by Country/Region (2019-2024)
4.2.1 Global Respiratory Syncytial Virus Vaccine for Children Annual Sales by Country/Region (2019-2024)
4.2.2 Global Respiratory Syncytial Virus Vaccine for Children Annual Revenue by Country/Region (2019-2024)
4.3 Americas Respiratory Syncytial Virus Vaccine for Children Sales Growth
4.4 APAC Respiratory Syncytial Virus Vaccine for Children Sales Growth
4.5 Europe Respiratory Syncytial Virus Vaccine for Children Sales Growth
4.6 Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Sales Growth
5 AMERICAS
5.1 Americas Respiratory Syncytial Virus Vaccine for Children Sales by Country
5.1.1 Americas Respiratory Syncytial Virus Vaccine for Children Sales by Country (2019-2024)
5.1.2 Americas Respiratory Syncytial Virus Vaccine for Children Revenue by Country (2019-2024)
5.2 Americas Respiratory Syncytial Virus Vaccine for Children Sales by Type (2019-2024)
5.3 Americas Respiratory Syncytial Virus Vaccine for Children Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Respiratory Syncytial Virus Vaccine for Children Sales by Region
6.1.1 APAC Respiratory Syncytial Virus Vaccine for Children Sales by Region (2019-2024)
6.1.2 APAC Respiratory Syncytial Virus Vaccine for Children Revenue by Region (2019-2024)
6.2 APAC Respiratory Syncytial Virus Vaccine for Children Sales by Type (2019-2024)
6.3 APAC Respiratory Syncytial Virus Vaccine for Children Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Respiratory Syncytial Virus Vaccine for Children by Country
7.1.1 Europe Respiratory Syncytial Virus Vaccine for Children Sales by Country (2019-2024)
7.1.2 Europe Respiratory Syncytial Virus Vaccine for Children Revenue by Country (2019-2024)
7.2 Europe Respiratory Syncytial Virus Vaccine for Children Sales by Type (2019-2024)
7.3 Europe Respiratory Syncytial Virus Vaccine for Children Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Respiratory Syncytial Virus Vaccine for Children by Country
8.1.1 Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Sales by Country (2019-2024)
8.1.2 Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Revenue by Country (2019-2024)
8.2 Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Sales by Type (2019-2024)
8.3 Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Respiratory Syncytial Virus Vaccine for Children
10.3 Manufacturing Process Analysis of Respiratory Syncytial Virus Vaccine for Children
10.4 Industry Chain Structure of Respiratory Syncytial Virus Vaccine for Children
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Respiratory Syncytial Virus Vaccine for Children Distributors
11.3 Respiratory Syncytial Virus Vaccine for Children Customer
12 WORLD FORECAST REVIEW FOR RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN BY GEOGRAPHIC REGION
12.1 Global Respiratory Syncytial Virus Vaccine for Children Market Size Forecast by Region
12.1.1 Global Respiratory Syncytial Virus Vaccine for Children Forecast by Region (2025-2030)
12.1.2 Global Respiratory Syncytial Virus Vaccine for Children Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Respiratory Syncytial Virus Vaccine for Children Forecast by Type (2025-2030)
12.7 Global Respiratory Syncytial Virus Vaccine for Children Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Moderna
13.1.1 Moderna Company Information
13.1.2 Moderna Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
13.1.3 Moderna Respiratory Syncytial Virus Vaccine for Children Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Moderna Main Business Overview
13.1.5 Moderna Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
13.2.3 Sanofi Respiratory Syncytial Virus Vaccine for Children Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Meissa
13.3.1 Meissa Company Information
13.3.2 Meissa Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
13.3.3 Meissa Respiratory Syncytial Virus Vaccine for Children Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Meissa Main Business Overview
13.3.5 Meissa Latest Developments
13.4 Blue Lake Biotechnology
13.4.1 Blue Lake Biotechnology Company Information
13.4.2 Blue Lake Biotechnology Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
13.4.3 Blue Lake Biotechnology Respiratory Syncytial Virus Vaccine for Children Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Blue Lake Biotechnology Main Business Overview
13.4.5 Blue Lake Biotechnology Latest Developments
13.5 Codagenix
13.5.1 Codagenix Company Information
13.5.2 Codagenix Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
13.5.3 Codagenix Respiratory Syncytial Virus Vaccine for Children Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Codagenix Main Business Overview
13.5.5 Codagenix Latest Developments
13.6 Novavax
13.6.1 Novavax Company Information
13.6.2 Novavax Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
13.6.3 Novavax Respiratory Syncytial Virus Vaccine for Children Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Novavax Main Business Overview
13.6.5 Novavax Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
13.7.3 Pfizer Respiratory Syncytial Virus Vaccine for Children Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Wits Health Consortium (Pty) Ltd
13.8.1 Wits Health Consortium (Pty) Ltd Company Information
13.8.2 Wits Health Consortium (Pty) Ltd Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
13.8.3 Wits Health Consortium (Pty) Ltd Respiratory Syncytial Virus Vaccine for Children Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Wits Health Consortium (Pty) Ltd Main Business Overview
13.8.5 Wits Health Consortium (Pty) Ltd Latest Developments
13.9 Advaccine
13.9.1 Advaccine Company Information
13.9.2 Advaccine Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
13.9.3 Advaccine Respiratory Syncytial Virus Vaccine for Children Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Advaccine Main Business Overview
13.9.5 Advaccine Latest Developments
13.10 Clover Biopharma
13.10.1 Clover Biopharma Company Information
13.10.2 Clover Biopharma Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
13.10.3 Clover Biopharma Respiratory Syncytial Virus Vaccine for Children Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Clover Biopharma Main Business Overview
13.10.5 Clover Biopharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Respiratory Syncytial Virus Vaccine for Children Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Respiratory Syncytial Virus Vaccine for Children Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Recombinant Protein Vaccine
Table 4. Major Players of Nucleic Acid Vaccine
Table 5. Major Players of Others
Table 6. Global Respiratory Syncytial Virus Vaccine for Children Sales byType (2019-2024) & (Dose)
Table 7. Global Respiratory Syncytial Virus Vaccine for Children Sales Market Share byType (2019-2024)
Table 8. Global Respiratory Syncytial Virus Vaccine for Children Revenue byType (2019-2024) & ($ million)
Table 9. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market Share byType (2019-2024)
Table 10. Global Respiratory Syncytial Virus Vaccine for Children Sale Price byType (2019-2024) & (US$/Dose)
Table 11. Global Respiratory Syncytial Virus Vaccine for Children Sale by Application (2019-2024) & (Dose)
Table 12. Global Respiratory Syncytial Virus Vaccine for Children Sale Market Share by Application (2019-2024)
Table 13. Global Respiratory Syncytial Virus Vaccine for Children Revenue by Application (2019-2024) & ($ million)
Table 14. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Application (2019-2024)
Table 15. Global Respiratory Syncytial Virus Vaccine for Children Sale Price by Application (2019-2024) & (US$/Dose)
Table 16. Global Respiratory Syncytial Virus Vaccine for Children Sales by Company (2019-2024) & (Dose)
Table 17. Global Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Company (2019-2024)
Table 18. Global Respiratory Syncytial Virus Vaccine for Children Revenue by Company (2019-2024) & ($ millions)
Table 19. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Company (2019-2024)
Table 20. Global Respiratory Syncytial Virus Vaccine for Children Sale Price by Company (2019-2024) & (US$/Dose)
Table 21. Key Manufacturers Respiratory Syncytial Virus Vaccine for Children Producing Area Distribution and Sales Area
Table 22. Players Respiratory Syncytial Virus Vaccine for Children Products Offered
Table 23. Respiratory Syncytial Virus Vaccine for Children Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Respiratory Syncytial Virus Vaccine for Children Sales by Geographic Region (2019-2024) & (Dose)
Table 27. Global Respiratory Syncytial Virus Vaccine for Children Sales Market Share Geographic Region (2019-2024)
Table 28. Global Respiratory Syncytial Virus Vaccine for Children Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Respiratory Syncytial Virus Vaccine for Children Sales by Country/Region (2019-2024) & (Dose)
Table 31. Global Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Country/Region (2019-2024)
Table 32. Global Respiratory Syncytial Virus Vaccine for Children Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Respiratory Syncytial Virus Vaccine for Children Sales by Country (2019-2024) & (Dose)
Table 35. Americas Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Country (2019-2024)
Table 36. Americas Respiratory Syncytial Virus Vaccine for Children Revenue by Country (2019-2024) & ($ millions)
Table 37. Americas Respiratory Syncytial Virus Vaccine for Children Sales byType (2019-2024) & (Dose)
Table 38. Americas Respiratory Syncytial Virus Vaccine for Children Sales by Application (2019-2024) & (Dose)
Table 39. APAC Respiratory Syncytial Virus Vaccine for Children Sales by Region (2019-2024) & (Dose)
Table 40. APAC Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Region (2019-2024)
Table 41. APAC Respiratory Syncytial Virus Vaccine for Children Revenue by Region (2019-2024) & ($ millions)
Table 42. APAC Respiratory Syncytial Virus Vaccine for Children Sales byType (2019-2024) & (Dose)
Table 43. APAC Respiratory Syncytial Virus Vaccine for Children Sales by Application (2019-2024) & (Dose)
Table 44. Europe Respiratory Syncytial Virus Vaccine for Children Sales by Country (2019-2024) & (Dose)
Table 45. Europe Respiratory Syncytial Virus Vaccine for Children Revenue by Country (2019-2024) & ($ millions)
Table 46. Europe Respiratory Syncytial Virus Vaccine for Children Sales byType (2019-2024) & (Dose)
Table 47. Europe Respiratory Syncytial Virus Vaccine for Children Sales by Application (2019-2024) & (Dose)
Table 48. Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Sales by Country (2019-2024) & (Dose)
Table 49. Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Country (2019-2024)
Table 50. Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Sales byType (2019-2024) & (Dose)
Table 51. Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Sales by Application (2019-2024) & (Dose)
Table 52. Key Market Drivers & Growth Opportunities of Respiratory Syncytial Virus Vaccine for Children
Table 53. Key Market Challenges & Risks of Respiratory Syncytial Virus Vaccine for Children
Table 54. Key IndustryTrends of Respiratory Syncytial Virus Vaccine for Children
Table 55. Respiratory Syncytial Virus Vaccine for Children Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Respiratory Syncytial Virus Vaccine for Children Distributors List
Table 58. Respiratory Syncytial Virus Vaccine for Children Customer List
Table 59. Global Respiratory Syncytial Virus Vaccine for Children SalesForecast by Region (2025-2030) & (Dose)
Table 60. Global Respiratory Syncytial Virus Vaccine for Children RevenueForecast by Region (2025-2030) & ($ millions)
Table 61. Americas Respiratory Syncytial Virus Vaccine for Children SalesForecast by Country (2025-2030) & (Dose)
Table 62. Americas Respiratory Syncytial Virus Vaccine for Children Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 63. APAC Respiratory Syncytial Virus Vaccine for Children SalesForecast by Region (2025-2030) & (Dose)
Table 64. APAC Respiratory Syncytial Virus Vaccine for Children Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 65. Europe Respiratory Syncytial Virus Vaccine for Children SalesForecast by Country (2025-2030) & (Dose)
Table 66. Europe Respiratory Syncytial Virus Vaccine for Children RevenueForecast by Country (2025-2030) & ($ millions)
Table 67. Middle East & Africa Respiratory Syncytial Virus Vaccine for Children SalesForecast by Country (2025-2030) & (Dose)
Table 68. Middle East & Africa Respiratory Syncytial Virus Vaccine for Children RevenueForecast by Country (2025-2030) & ($ millions)
Table 69. Global Respiratory Syncytial Virus Vaccine for Children SalesForecast byType (2025-2030) & (Dose)
Table 70. Global Respiratory Syncytial Virus Vaccine for Children RevenueForecast byType (2025-2030) & ($ millions)
Table 71. Global Respiratory Syncytial Virus Vaccine for Children SalesForecast by Application (2025-2030) & (Dose)
Table 72. Global Respiratory Syncytial Virus Vaccine for Children RevenueForecast by Application (2025-2030) & ($ millions)
Table 73. Moderna Basic Information, Respiratory Syncytial Virus Vaccine for Children Manufacturing Base, Sales Area and Its Competitors
Table 74. Moderna Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
Table 75. Moderna Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 76. Moderna Main Business
Table 77. Moderna Latest Developments
Table 78. Sanofi Basic Information, Respiratory Syncytial Virus Vaccine for Children Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
Table 80. Sanofi Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 81. Sanofi Main Business
Table 82. Sanofi Latest Developments
Table 83. Meissa Basic Information, Respiratory Syncytial Virus Vaccine for Children Manufacturing Base, Sales Area and Its Competitors
Table 84. Meissa Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
Table 85. Meissa Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 86. Meissa Main Business
Table 87. Meissa Latest Developments
Table 88. Blue Lake Biotechnology Basic Information, Respiratory Syncytial Virus Vaccine for Children Manufacturing Base, Sales Area and Its Competitors
Table 89. Blue Lake Biotechnology Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
Table 90. Blue Lake Biotechnology Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 91. Blue Lake Biotechnology Main Business
Table 92. Blue Lake Biotechnology Latest Developments
Table 93. Codagenix Basic Information, Respiratory Syncytial Virus Vaccine for Children Manufacturing Base, Sales Area and Its Competitors
Table 94. Codagenix Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
Table 95. Codagenix Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 96. Codagenix Main Business
Table 97. Codagenix Latest Developments
Table 98. Novavax Basic Information, Respiratory Syncytial Virus Vaccine for Children Manufacturing Base, Sales Area and Its Competitors
Table 99. Novavax Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
Table 100. Novavax Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 101. Novavax Main Business
Table 102. Novavax Latest Developments
Table 103. Pfizer Basic Information, Respiratory Syncytial Virus Vaccine for Children Manufacturing Base, Sales Area and Its Competitors
Table 104. Pfizer Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
Table 105. Pfizer Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 106. Pfizer Main Business
Table 107. Pfizer Latest Developments
Table 108. Wits Health Consortium (Pty) Ltd Basic Information, Respiratory Syncytial Virus Vaccine for Children Manufacturing Base, Sales Area and Its Competitors
Table 109. Wits Health Consortium (Pty) Ltd Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
Table 110. Wits Health Consortium (Pty) Ltd Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 111. Wits Health Consortium (Pty) Ltd Main Business
Table 112. Wits Health Consortium (Pty) Ltd Latest Developments
Table 113. Advaccine Basic Information, Respiratory Syncytial Virus Vaccine for Children Manufacturing Base, Sales Area and Its Competitors
Table 114. Advaccine Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
Table 115. Advaccine Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 116. Advaccine Main Business
Table 117. Advaccine Latest Developments
Table 118. Clover Biopharma Basic Information, Respiratory Syncytial Virus Vaccine for Children Manufacturing Base, Sales Area and Its Competitors
Table 119. Clover Biopharma Respiratory Syncytial Virus Vaccine for Children Product Portfolios and Specifications
Table 120. Clover Biopharma Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 121. Clover Biopharma Main Business
Table 122. Clover Biopharma Latest Developments
LIST OFFIGURES
Figure 1. Picture of Respiratory Syncytial Virus Vaccine for Children
Figure 2. Respiratory Syncytial Virus Vaccine for Children Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Respiratory Syncytial Virus Vaccine for Children Sales Growth Rate 2019-2030 (Dose)
Figure 7. Global Respiratory Syncytial Virus Vaccine for Children Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Respiratory Syncytial Virus Vaccine for Children Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Country/Region (2023)
Figure 10. Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Recombinant Protein Vaccine
Figure 12. Product Picture of Nucleic Acid Vaccine
Figure 13. Product Picture of Others
Figure 14. Global Respiratory Syncytial Virus Vaccine for Children Sales Market Share byType in 2023
Figure 15. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market Share byType (2019-2024)
Figure 16. Respiratory Syncytial Virus Vaccine for Children Consumed in Hospital
Figure 17. Global Respiratory Syncytial Virus Vaccine for Children Market: Hospital (2019-2024) & (Dose)
Figure 18. Respiratory Syncytial Virus Vaccine for Children Consumed in Centers for Disease Control and Prevention
Figure 19. Global Respiratory Syncytial Virus Vaccine for Children Market: Centers for Disease Control and Prevention (2019-2024) & (Dose)
Figure 20. Respiratory Syncytial Virus Vaccine for Children Consumed in Others
Figure 21. Global Respiratory Syncytial Virus Vaccine for Children Market: Others (2019-2024) & (Dose)
Figure 22. Global Respiratory Syncytial Virus Vaccine for Children Sale Market Share by Application (2023)
Figure 23. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Application in 2023
Figure 24. Respiratory Syncytial Virus Vaccine for Children Sales by Company in 2023 (Dose)
Figure 25. Global Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Company in 2023
Figure 26. Respiratory Syncytial Virus Vaccine for Children Revenue by Company in 2023 ($ millions)
Figure 27. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Company in 2023
Figure 28. Global Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Geographic Region in 2023
Figure 30. Americas Respiratory Syncytial Virus Vaccine for Children Sales 2019-2024 (Dose)
Figure 31. Americas Respiratory Syncytial Virus Vaccine for Children Revenue 2019-2024 ($ millions)
Figure 32. APAC Respiratory Syncytial Virus Vaccine for Children Sales 2019-2024 (Dose)
Figure 33. APAC Respiratory Syncytial Virus Vaccine for Children Revenue 2019-2024 ($ millions)
Figure 34. Europe Respiratory Syncytial Virus Vaccine for Children Sales 2019-2024 (Dose)
Figure 35. Europe Respiratory Syncytial Virus Vaccine for Children Revenue 2019-2024 ($ millions)
Figure 36. Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Sales 2019-2024 (Dose)
Figure 37. Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Revenue 2019-2024 ($ millions)
Figure 38. Americas Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Country in 2023
Figure 39. Americas Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Country (2019-2024)
Figure 40. Americas Respiratory Syncytial Virus Vaccine for Children Sales Market Share byType (2019-2024)
Figure 41. Americas Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Application (2019-2024)
Figure 42. United States Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 43. Canada Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 44. Mexico Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 45. Brazil Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 46. APAC Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Region in 2023
Figure 47. APAC Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Region (2019-2024)
Figure 48. APAC Respiratory Syncytial Virus Vaccine for Children Sales Market Share byType (2019-2024)
Figure 49. APAC Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Application (2019-2024)
Figure 50. China Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 51. Japan Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 52. South Korea Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 53. Southeast Asia Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 54. India Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 55. Australia Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 56. ChinaTaiwan Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 57. Europe Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Country in 2023
Figure 58. Europe Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Country (2019-2024)
Figure 59. Europe Respiratory Syncytial Virus Vaccine for Children Sales Market Share byType (2019-2024)
Figure 60. Europe Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Application (2019-2024)
Figure 61. Germany Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 62.France Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 63. UK Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 64. Italy Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 65. Russia Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 66. Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Country (2019-2024)
Figure 67. Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Sales Market Share byType (2019-2024)
Figure 68. Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Application (2019-2024)
Figure 69. Egypt Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 70. South Africa Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 71. Israel Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 72.Turkey Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 73. GCC Countries Respiratory Syncytial Virus Vaccine for Children Revenue Growth 2019-2024 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Respiratory Syncytial Virus Vaccine for Children in 2023
Figure 75. Manufacturing Process Analysis of Respiratory Syncytial Virus Vaccine for Children
Figure 76. Industry Chain Structure of Respiratory Syncytial Virus Vaccine for Children
Figure 77. Channels of Distribution
Figure 78. Global Respiratory Syncytial Virus Vaccine for Children Sales MarketForecast by Region (2025-2030)
Figure 79. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market ShareForecast by Region (2025-2030)
Figure 80. Global Respiratory Syncytial Virus Vaccine for Children Sales Market ShareForecast byType (2025-2030)
Figure 81. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market ShareForecast byType (2025-2030)
Figure 82. Global Respiratory Syncytial Virus Vaccine for Children Sales Market ShareForecast by Application (2025-2030)
Figure 83. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market ShareForecast by Application (2025-2030)
